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Abstract The quality-adjusted life-year (QALY) has
become a widely used measure of health outcomes for use
in informing decision making in health technology
assessment. However, there is growing recognition of
outcomes beyond health within the health sector and in
related sectors such as social care and public health. This
paper presents the advantages and disadvantages of ten
possible approaches covering extending the health-related
QALY and using well-being and monetary-based methods,
in order to address the problem of using multiple outcome
measures to inform resource allocation within and between
sectors.
Key Points for Decision Makers
Quality-adjusted life-years (QALYs) are
traditionally health related and so do not cover all the
things that may matter to decision makers in health
and related sectors.
There are numerous alternatives from extending the
existing health measures to using a broader notion of
well-being or monetary-based approaches.
Ultimately, there are important value judgements to
be made about what matters in public policy.
1 Background
The quality-adjusted life-year (QALY) has become a
widely used measure of outcome for use in informing
decision making in health technology assessment. QALYs
are commonly estimated using preference-based measures
such as the EQ-5D, SF-6D and HUI3 [1–3]. The most
widely used instrument for estimating the quality of life
component of the QALYs has been the EQ-5D [4]. EQ-5D
is designed to measure an individual’s generic health status
(or health-related quality of life) across five dimensions:
personal functioning (with mobility and self-care); activi-
ties (usual activities); pain or discomfort; and anxiety or
depression, each with three levels [5]. It has an accompa-
nying preference-based value set obtained from the general
public using a variant of time trade-off (TTO) [1]. There is
currently research into the valuation of a new 5-level ver-
sion [6]. EQ-5D is the preferred measure for use in
assessing the cost effectiveness of health technologies for
NICE [7], and it is used in the NHS Executive’s PROM
(Patient Reported Outcome Measures) programme.
However, there is recognition of outcomes beyond
health and that measures such as EQ-5D are not adequate
in related sectors such as social care and public health.
Even in health care, for some conditions EQ-5D does not
capture all the things that matter to patients [8]. In social
care there has been the development of the Adult Social
Care Outcome Tool (ASCOT) for routine use in social
services [9]. In public health, there is no single measure but
there are a number of broader measures that could be used,
including the preference-weighted ICECAP capability
index [10, 11], measures of well-being such as the War-
wick-Edinburgh Mental Well-Being Scale (WEMWBS)
[12] and the ONS-4 [13]. Most do not have any preference
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weighting; the only one that does (ICECAP) is not
anchored at 0 for being dead, which would allow them to
be used to estimate the quality adjustment component of
the QALY. The use of multiple outcome measures presents
decision makers (such as NICE) with the problem of how
to use such measures to make comparisons across sectors
or how to combine them to provide an overall measure of
benefit whilst avoiding double counting.
2 Aim
The UK Medical Research Council (MRC) sought to
examine alternatives to the health-related QALY to address
the problem of using multiple outcome measures to inform
resource allocation within and between sectors. To this end
it commissioned this review of the alternatives in order to
inform its recent highlight notice to encourage research
applications in the area [14]. It does not claim to be a full
systematic review, nor has it identified all possible alter-
natives. This review aims to provide an overview of a
representative list of ten approaches, and presents the
advantages and disadvantages of each and identifies
research required to develop them further.
This review does not go in to details of the methods of
valuation, which include TTO, standard gamble, visual
analogue scale, discrete choice experiments (DCEs), and
person trade-off. The DALY (disability-adjusted life-year)
is not reviewed, although its 2010 version now uses general
public preferences as the basis of disability weights [15].
This is because its aim is to quantify the burden of disease,
or loss of health, as opposed to loss of welfare/well-being
[16]. We exclude approaches based on the valuation of
whole time profiles of health, such as healthy year equiv-
alents [17], since the focus of this paper is on the use of
standardised measures (e.g. EQ-5D, ASCOT and
WEMWBS). Finally, this review does not address in any
detail the implications for economic evaluation studies.
3 The Main Approaches
The ten main approaches reviewed in this paper are clas-
sified under three headings: those looking to extend the
existing health-related QALYs, those using well-being and
those using money to value outcomes.
Extending the QALY beyond health:
A. Statistical mapping to EQ-5D.
B. Bolting on to EQ-5D.
C. Valuing on a common scale using preferences.
Using well-being to value outcomes:
D. Valuing by association with well-being.
E. Developing a well-being-adjusted life-year (WELBY).
F. Direct valuation of own health or well-being states.
Using money to value outcomes:
G. Public sector implied willingness to pay (WTP).
H. Contingent valuation using WTP (welfarist).
I. Societal WTP (non-welfarist).
J. Monetarise health and other outcomes using
experience.
3.1 Extending the QALY Beyond Health
A. Statistical mapping to EQ-5D.
Most statistical mapping is from a non-preference-based
and/or condition-specific measure to a preference-based
generic measure such as the EQ-5D. Mapping is one option
recommended by NICE [7] to estimate EQ-5D utility data
when EQ-5D data are unavailable in the study dataset.
Estimating a mapping function between EQ-5D and
another instrument (e.g. ASCOT) would require both to be
collected together in one or more datasets. A mapping
function could be estimated by regression which would
enable any ASCOT state to be linked to an estimated value
for the EQ-5D. There are a variety of specifications that
can be fitted to the data and different statistical techniques
for dealing with the distributions of the variables involved
(see examples from health care) [18–20]. This would mean
that if an evaluation of a social care intervention collected
only the ASCOT measure then these data could be used to
estimate EQ-5D values.
However, the mapping function relies on statistical
association and this is unlikely to be strong given the low
conceptual overlap between ASCOT and EQ-5D. EQ-5D is
about the key five aspects of a person’s health, whereas
ASCOT is concerned with the way a person’s health—
combined with their socio-economic status, home circum-
stances (including availability of informal care), and the
social care services they receive—impacts their overall
quality of life defined in terms of the extent to which their
needs and wants are being met. For example, the same
(poor) health in EQ-5D can impact a person’s ASCOT
score in different ways depending on the availability and
quality of informal and formal care provision. At the same
time, the provision of good social care may result in dif-
ferent levels of EQ-5D health achieving the same ASCOT
score. The descriptive systems are simply not measuring
the same thing. There are similar problems in trying to map
from ICECAP or WEMWBS to EQ-5D.
In these circumstances the EQ-5D would be unable to
reflect many of the outcomes captured by the other measure
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and so direct statistical mapping would not be an appro-
priate solution.
B. Bolting on dimensions to EQ-5D.
Another alternative approach when EQ-5D does not
cover the relevant outcomes is to expand the measure by
including ‘bolt-on’ dimensions to cover the dimensions
missing from the measure. Bolt-on dimensions to EQ-5D
have been developed for cognition [21], sleep [22], energy,
vision and hearing [8]. Recently, there was a study looking
at the addition of satisfaction [23]. The wording of these
dimensions tends to conform to the format of the EQ-5D
dimensions: no problem, some problem and severe prob-
lem. To be useful, these bolt-ons need to be incorporated
into the EQ-5D preference-based value set so they can be
compared with the impact of the other dimensions and
between bolt-ons. There is evidence that the addition of a
dimension has consequences for the value of the other
dimensions; for example, a vision bolt-on was found to
reduce the coefficient on usual activity [8], implying a need
for the re-valuation of the EQ-5D value sets with the bolt-
on (see item D below for ‘generalised’ TTO).
This solution has a more fundamental limitation since
the problem is often not simply the absence of one or two
dimensions. The use of bolt-ons may have potential within
health care where there are just one or two missing
dimensions, but there is little conceptual similarity between
measures such as EQ-5D, ASCOT, ICECAP and
WEMWBS. Furthermore, there is a limit to the number of
dimensions that a descriptive system can have for it to be
amenable to valuation tasks such as TTO or DCE. Fur-
thermore, there is a risk of double counting since the
dimensions in one measure may be captured to some extent
by dimensions in the other measure; for example, ability to
meet personal care needs may be partly reflected in the
self-care dimension of EQ-5D. There would seem little
value in pursuing research into this approach for tackling
cross-sectorial issues.
C. Valuing on a common scale using preferences.
QALYs are based on the elicitation of the preferences
of the population for living in different health states. The
EQ-5D was valued using TTO, where a respondent is
asked to compare a life of 10 years in a given ill health
state with a shorter period in full health. The period in full
health is varied until the individual is indifferent between
health state z for 10 years and full health for x years, at
which point the value or the quality adjustment weight of
state z is derived as x/10 [24]. This means all EQ-5D
states are valued on a scale with zero for dead and one for
full health. From a theoretical perspective, choice-based
methods such as TTO imply that the quality adjustment of
the QALY is equivalent to an overall well-being adjust-
ment—everything of value to an individual will be
incorporated into it. In a TTO exercise, if the individual is
indifferent between health state z for 10 years and full
health for 6, each year in this health state is valued at 0.6.
The difference between state z and ‘full health’ is being
valued in terms of everything which is important about
being alive, as it is not just the 4 years of health which is
traded off, but 4 years of life.
Thus, TTO can be argued to capture more than health
through the impact of health on overall quality of life,
though this is limited by the accuracy with which a
respondent is able to imagine these broader impacts (see
discussion under approach F on direct valuation). Choice-
based techniques like TTO could provide a way to compare
measures like EQ-5D and ASCOT, which have been val-
ued using this method. However, TTO tasks used to value
these instruments differed in a crucial way—the upper
anchor (viz. the better state in shorter duration) tends to be
instrument specific: for EQ-5D it was EQ-5D state 11111
(no health problems) and for ASCOT it was ASCOT state
11111111 (meeting social-care-related needs and wants).
These upper anchors are not the same, which may result in
important differences in the scales.
What is required is a common yardstick. Exploratory
research funded by MRC examined the use of a generic
Visual Analogies Scale (VAS) (best imaginable to worst
imaginable life) and ranking methods to value a number of
measures including EQ-5D, an earlier version of ASCOT,
ICECAP, and an asthma-specific measure [25, 26]. This
enabled the estimation of exchange rates between these
measures. This approach could be extended to a choice-
based valuation technique such as TTO, where the upper
anchor is not instrument specific but described in more
general terms such as ‘best imaginable state’. In a more
explicit way, respondents are being asked to value states
defined by EQ-5D and ASCOT in terms of how many years
of best imaginable life they would be willing to sacrifice.
Once a sample of states from the two instruments have
been valued in this way it would be possible to map
between them using the common scale.
However, concerns still remain. For example, when
valuing EQ-5D the respondent’s attention is focused on the
particular aspects of health and they are typically not
encouraged to think more broadly about their life. It is not
clear what they imagine will happen to other aspects of
their life like job, income, relationships, well-being and so
forth. The nature and extent of this problem could be
investigated using mixed methods, including in-depth
interviews into what respondents say they are taking into
account in the task and empirical work into the impact of
these factors in the valuation of states.
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3.2 Using Well-Being
The approaches described so far in this document are
reliant on the use of preference, elicited using techniques
such as TTO where respondents are being asked to imagine
health or social care states. These approaches assume that
individuals are able to predict the likely impact of the
health state being described on their future lives, but this
has been shown not to be the case in health and other
contexts [27]. General population respondents to health
valuation surveys imagining health states, for example,
usually do not take into account the extent of any adapta-
tion they may make over time [28]. So their preferences
will provide a poor indicator of the actual impact on their
well-being. This is one of the reasons why some econo-
mists have advocated the use of more direct measurements
of well-being in those experiencing the health states
through measures of subjective well-being [27].
This raises the issue of what is well-being. Well-being,
broadly conceived, is how well an individual’s life is
going. Subjective well-being (SWB) has been described
under three headings: hedonism (well-being increases
when an individual experiences more pleasure and/or less
pain), flourishing theories (well-being increases when an
individual fulfils their nature as a human being, or ‘flour-
ishes’) and life evaluation or life satisfaction (well-being
increases when an individual positively assesses her life)
[29]. Traditionally, there are also objective list accounts of
well-being including items such as literacy, accommoda-
tion and ability to see [30].
The well-being literature has seen the rise of the use of
Sen’s notion of a capability set. Capability sets are made up
of those things you can do or be [31]. He advocated the use
of capability sets in response to concerns about an over-
reliance on outcomes and utilities in economics. Sen
argued that society is interested with what you can do or
be, rather than what you actually choose (or happen) to do
or be. This contrasts with conventional consequentialist
measures like EQ-5D. Although Sen remains reluctant to
set out a definitive list of capabilities, there have been
several attempts [10, 32, 33]; the problem is that it is
doubtful whether capability sets can be measured using
questionnaires [34]. An attempt to measure capabilities in
health care is the ICECAP [10], which tries to achieve this
by asking respondents whether they ‘can have…’ or ‘are
able to…’. The content of having achieved as much as they
would like is similar in content to measures of psycho-
logical well-being.
There are a number of tools available to measure SWB,
including simple self-reported items on happiness and life
satisfaction, and multi-item measures of psychological
well-being such as WEMWBS [12]. In addition, some
economists have used TTO or other techniques directly in
people suffering ill-health in order to get their preference-
based value. One of the issues in applying well-being
approaches has been deciding which measure to use, but
here we focus on describing the different approaches to
using well-being.
D. Valuing by association with well-being.
Some economists have advocated the measurement of
cardinal utility in terms of subjective well-being, such as
affect (e.g. pleasure and pain) or life satisfaction [27].
These well-being scales can be used as dependent variables
for estimating the impact of measures like EQ-5D or
ASCOT on well-being. These studies have used regression
techniques to estimate weights for EQ-5D and SF-6D,
including self-reported happiness and satisfaction items
[35, 36].
The use of well-being measures is currently limited by
the fact that they are often unscored single items or, where
there are multiple items, they are simply summed together
or valued using the output of psychometric techniques like
Rasch [37]. This makes interpretation of the scores prob-
lematic since they do not provide a cardinal measure. In the
future, it may be possible to generate a multi-item instru-
ment which generates a cardinal score that has something
close to interval properties. This would provide a basis for
comparison across measures on a common scale.
Another limitation with this approach is that the well-
being scales are not anchored on the zero to one scale
which is required to calculate QALYs. This limits the
application in health (and social care) where mortality is
often a key outcome. Perhaps more fundamentally it
assumes that the association between health and well-being
represents causality. This limitation could be addressed by
more sophisticated modelling of longitudinal data con-
taining the measures of interest. However, it is unlikely that
such data sets exist for measures outside of health. It also
relies on an acceptance of the validity of well-being mea-
sures for making inter-personal comparison. Further
research is required to estimate and develop a well-being
scale that is cardinal with interval properties on a scale
where zero is anchored on dead, and to examine longitu-
dinal data sets. This would require primary research into
the development of a WELBY (as described in the next
section), as well as analyses of secondary data sources.
E. Developing a well-being-adjusted life-year (WELBY).
A WELBY is the same as a QALY measure like EQ-5D,
except the descriptive system is concerned with well-being
rather than just health-related quality of life. A multi-di-
mensional well-being classification system like EQ-5D
could be formed from measures such as the ICECAP,
ONS-4 or WEMWBS and valued using a generic TTO or
other preference elicitation techniques.
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A WELBY could be used to measure benefits across
sectors, permit comparisons of efficiency across sectors,
and be used within the existing framework of economic
evaluation. It would allow comparisons of the incremental
cost per QALY across sectors and could provide a new and
radical way of asking questions of the current resource
allocation levels between sectors. The disadvantage is that
these general subjective well-being measures are less
specific and have been shown to have lower levels of
sensitivity than more sector-specific measures such as EQ-
5D and ASCOT [38]. A more fundamental concern is that,
in order to value a WELBY, preferences are being used and
these have been criticised for being poor indicators of the
way health impacts on a person’s life. However, in the
context of a WELBY, it is preferences over well-being
rather than health and so should be less prone to this
problem.
Research should be undertaken to develop a WELBY to
be used across the public sector in order to examine the
extent of the implications of these limitations. It would be
easier to use an existing well-being measure rather than
develop an entirely new one, through statistical mapping
between a new WELBY scale and existing measures of
SWB.
F. Direct valuation of own health or well-being states.
This approach asks patients and other individuals who
are experiencing any given state to value it. It is an
approach that avoids the need for a description of health,
such as the EQ-5D, or for well-being, such as the
WEMWBS. It could be done using a well-being scale, but
as already mentioned this has the problem of not being
commensurate with survival which is a major limitation in
health care. Preference elicitation techniques such as TTO
can be used in order to anchor responses onto the full well-
being—dead scale used to calculate QALYs. This and
other techniques have been used in healthcare patient
populations, where the upper anchor tends to be full health
[28], but it has not been used in other sectors.
This approach gets to the heart of an important norma-
tive issue as to whether resources should be allocated on
the basis of some aggregated societal valuation, as is the
current method, or some aggregation of values from actual
users of the services. The argument for users such as
patients is that they know the impact of their own state on
their lives better than someone trying to imagine it using
the highly stylised descriptions of measures like EQ-5D or
well-being scales like WEMWBS. For example, people
tend to under-estimate the extent to which they can adapt to
physical health states in the longer term, and so provide
significantly lower values [39].
Another concern is that well-being is prone to adapta-
tion, resulting in low expectations and even denial effects.
Direct value elicitation has also been criticised on the
grounds that it involves imagining the best state and for
someone with long-term conditions this is quite hypothet-
ical [39]. There are also practical problems with obtaining
values from a representative sample of users, including
those who are in poorer states who may be unwilling to
perform such a task and indeed it may be unethical to ask
individuals in terminal states the life and death questions
involved in these elicitation techniques.
This approach has been used for many years and there
are some reviews of the results compared with general
population samples [38]. However, it has not been used
extensively and systematically across patient and other
service user populations. Further research could examine
the use of this approach more extensively and what it says
about the way people value their own state.
3.3 Using Money to Value Outcomes
Traditionally, economists have sought to undertake cost–
benefit analyses where all the costs and benefits are valued
in monetary terms. This enables the use of the decision rule
that an intervention should go ahead where there is a net
benefit in monetary terms [3]. This requires all benefits,
including any impact of health and well-being, to be valued
in monetary terms. This would enable the benefits in one
sector to be compared to another, though care would need
to be taken to ensure that double counting is avoided. There
are a variety of techniques for doing this and here we
outline a few approaches that may be considered in the
context of this review.
G. Public sector implied willingness to pay (WTP).
This approach utilises the fact of each government
department having its own annual budget constraint to
achieve their objectives. Under a constrained budget,
decision makers are allocating resources to competing
demands and these decisions imply relative values to dif-
ferent outcomes. The value of different outcomes is
revealed by the decisions being taken by policy makers,
whether or not these are optimal. The best example of this
is the cost per QALY threshold range used by NICE to
inform their decisions to recommend the funding of new
health technologies of £20,000–30,000 [7]. Recent empir-
ical evidence indicates that actual decisions made by the
NHS suggest the value may be significantly less than this
[40]. The threshold is interpreted to represent the amount
that relevant decision makers are willing to pay for a given
outcome. The research undertaken at the University of
York examined natural variation in expenditure across the
NHS and natural variation in mortality outcomes to esti-
mate these implied values. In principle, such threshold
values exist (if only implicitly) across other sectors, though
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there is little available evidence at present to estimate the
amounts. Once such values are available across sectors,
this approach can provide values for different outcomes
across sectors that can be used within a net benefit
framework [41]. When one sector (e.g. NHS) generates
benefits relevant to another sector (e.g. social services), the
beneficiary can compensate the sector producing the ben-
efit. In reality, it may not be possible to undertake actual
compensation, in which case a compensation test can
operate: if one sector could hypothetically compensate
another sector then the intervention/programme should go
ahead.
This approach presents some major empirical chal-
lenges, since other sectors do not have a threshold like
NICE. However, a simplified version of this framework
was developed by the Department of Health for Value
Based Pricing using a range of shadow prices for outcomes
in different sectors [42]. A criticism of using implied val-
ues is that they may not reflect the values of society.
Furthermore, outcomes across sectors are not unrelated and
so there is a risk of double counting. Taking the example of
EQ-5D and ASCOT, whilst they differ in many ways, there
is a significant degree of overlap in the dimensions they
cover and so they cannot simply be combined to generate a
total estimate of value.
The potential research required to take this approach
forward includes the explicit estimation of thresholds for
different outcomes across sectors (e.g. in social care) and
an investigation into the optimality of the implied values.
H. Welfarist WTP.
Public sector implied WTP above relies on the
assumptions that (a) actual resource allocation in the public
sector is efficient and (b) it reflects what the public want. A
more traditional approach in economics would be to value
non-market goods and services such as environmental
changes via ‘compensating variations’. This is the maxi-
mum amount of money that, following a good change, an
individual can pay and still maintain the level of welfare
they had prior to the change; thus the term ‘willingness to
pay’ (WTP). Typically, they will be elicited through
questionnaire surveys tapping into respondents’ decision
utility and preferences, using hypothetical scenarios to
value [43]. Compensating variation is a cardinal measure of
change in individual well-being, as assessed by the indi-
vidual themselves, and while the underlying individual
utility functions are not directly observed, the size of
compensating variations appear to be interpersonally
comparable. This has been challenged, because it seems
intuitively ‘wrong’ to say a compensating variation of, for
example, £100 means the same thing to a rich person and to
a poor person. Most welfare economists agree in principle
that to be interpersonally comparable (viz. to be of policy
relevance), compensating variation should be corrected for
income inequality by applying ‘distributional weights’
[44].
There are a number of different ways WTP could be
used to value cross-sector outcomes. The use of WTP in
health care tended to be mainly about the valuation of
specific interventions where the respondent is provided
with information about benefits including health, conve-
nience and the processes of care [45–47]. There have
been some applications to value a QALY through peo-
ple’s WTP to avoid some duration or risk of a health state
using EQ-5D [48]. However, the WTP method has not
been used to model monetary values for entire descriptive
systems to date [49]. Experience with NICE submissions
is that the use of such vignettes describing health and
other benefits is open to manipulation and carries less
weight than one based on patient-reported outcomes [7].
It has not been applied on a large scale like QALYs and it
would require a significant amount of work to
operationalise.
More generally, there is evidence from the WTP liter-
ature, mostly in environmental economics, regarding
insensitivity to scope and scale (i.e. things that WTP should
respond to) and sensitivity to framing (i.e. things that WTP
should not respond to) [50–52]. Furthermore, there are
concerns with using WTP to value healthcare services in a
system such as the UK NHS, where we do not pay for
health care out of pocket. It should also be noted that there
has been limited support for the use of WTP in the health
sector as a measure of change in individual well-being.
I. Non-welfarist WTP.
Compensating variation above is a concept based on
welfarist and individualist welfare economics. However,
monetary measures of health and well-being need not be
welfarist. Members of the public can be asked how much
money government should provide towards different poli-
cies, where outcomes might be described in terms of any of
the descriptive systems described above. The metric will be
directly comparable across sectors. Crucially, the payment
is not out of individual pockets, and so distributional
concerns are not an issue.
Some sporadic studies exist (e.g. [53]), but not as a
coherent body of literature, and this approach is the most
‘blue-sky’ of all approaches discussed in this paper. In
terms of economic evaluation, a non-welfarist variant of
the cost benefit analysis will be called for. It would not be
appropriate to use net benefit rules in a budget-constrained
public sector and so there will emerge cost per WTP
thresholds across each sector to inform investment and
disinvestment decisions as being used by NICE. However,
this information would provide a basis for making com-
parisons between sectors.
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J. Monetarise health and well-being using experience.
Another way to avoid the limitations of a lack of
anchoring of well-being and to improve interpersonal
comparability would be to estimate the relationship
between health and other outcomes in terms of income (i.e.
to monetise them) using a well-being equation. This
approach converts outcomes into money, but uses the rel-
ative impact of the outcome measure compared with
income on well-being to provide the calibration. The
method models the determinants of subjective well-being
in terms of health and other outcomes, and estimates
exchange rate, or marginal rate of substitution, between
income and health or social care with well-being as the
dependent variable. This approach has been used in the
context of health [54], but not social care or other out-
comes. Furthermore, monetary equivalent values change
depending on the well-being measure used [55]. Such
modelling needs to take into account the complexity of the
relationship since it is not uni-directional. This approach
need to be explored further.
4 Conclusion
There are ten approaches to address the problem raised of
how to compare outcomes across sectors and avoid double
counting. The approaches start from minor adjustments to
current methods and progress to options that depart in more
radical ways from the health-based QALY. These ten
approaches can be divided into three broad sets. The first
are those that would represent the least deviation from the
current practice of many agencies around the world of
using health-related QALYs in health care, by proposing to
either map other measures onto preference-based health
measures such as EQ-5D, to bolt on dimensions to the EQ-
5D as required, or to value all measures using a common
generic version of TTO. The second set of approaches uses
well-being in different ways to value outcomes across
sectors: by association with well-being measures, by direct
valuation of own health or well-being using TTO (or some
other preference-elicitation technique), or by developing a
WELBY. The final set of four approaches all use money as
the metric: those implied by decisions in the public sector,
contingent valuation using an individual’s stated WTP,
WTP from a societal perspective and monetising in terms
of the impact on well-being. Whilst these alternatives are
not exhaustive, they represent the range of alternatives
from the least to the most radical. There are other variants
of the methods and there are numerous detailed technical
issues about how they are to be implemented.
These approaches are not entirely mutually exclusive.
An extended health or well-being approach, for example,
could be used to describe the outcomes, but they can be
valued using a QALY type model (i.e. on the zero to one
scale) or monetised using various forms of WTP. Another
example is that any new well-being measure could be
mapped onto existing measures.
Any choice between these approaches involves impor-
tant political decisions about what counts in measuring the
benefits of interventions. An important example would be
the choice of whether to use a pure subjective well-being
measure such as happiness or life satisfaction to describe
the benefits, compared with more sector-specific outcomes
like EQ-5D or ASCOT. It may be that in the end policy
makers opt for a compromise involving subjective well-
being for the cross-sector comparisons but continuing to
use the sector-specific outcomes for within-sector decisions
since they are more sensitive. Furthermore, sector-specific
outcomes could be valued using subjective well-being (e.g.
approaches D or J) or money (e.g. H, I or J).
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